Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.
TROP2 抗体-药物偶联物 Datopotamab Deruxtecan 在患者来源的乳腺癌异种移植模型中的抗肿瘤活性和生物标志物分析
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1948
Meric-Bernstam Funda, Yuca Erkan, Evans Kurt W, Zhao Ming, Maejima Takanori, Karibe Tsuyoshi, Raso Maria Gabriela, Tang Ximing, Zheng Xiaofeng, Rizvi Yasmeen Qamar, Akcakanat Argun, Scott Stephen M, Wang Bailiang, Byers Lauren A, Tripathy Debu, Okajima Daisuke, Damodaran Senthil